Chemomab Therapeutics Ltd. buy Global_Player
Start price
19.01.25
/
50%
€2.12
Target price
19.01.26
-
Performance (%)
-6.60%
End price
01.02.25
€1.98
Summary
This prediction ended on 01.02.25 with a price of €1.98. With a performance of -6.60%, the BUY prediction by Global_Player finished with a loss. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Chemomab Therapeutics Ltd. | - | - | - |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
According to Global_Player what are the pros and cons of Chemomab Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Chemomab Therapeutics Ltd. diskutieren
Buy Chemomab Therapeutics Ltd.
In the thread Trading Chemomab Therapeutics Ltd.
Stopped prediction by Global_Player for Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.10
18.06.25
18.06.25
-
18.06.26
18.06.26
-3.64%
21.06.25
21.06.25
Could be worthwhile Investment >10% per year
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.14
24.03.25
24.03.25
-
24.03.26
24.03.26
-12.72%
29.03.25
29.03.25
Could be worthwhile Investment >10% per year
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.23
04.03.25
04.03.25
-
04.03.26
04.03.26
6.50%
15.03.25
15.03.25
Could be worthwhile Investment >10% per year